Skip to main content

HEDIS 2020 – What’s New, What’s Changing

November 21, 2019

To: All Providers

As the end of 2019 approaches, we want to summarize some of the HEDIS changes coming in 2020.


  • Breast cancer screening (BCS)
    • Updated CPT and ICD-10 codes to identify patients who may be excluded due to the advanced illness and frailty exclusion
  • Cervical cancer screening (CCS)
    • Screening methods updated to include primary high-risk HPV testing
  • Colorectal cancer screening (COL)
    • Compliance codes added for test results for both Fecal Occult Blood Test (FOBT) and Cologuard (FIT-DNA)
    • Hybrid specification updated to indicate a screening test result is not required ONLY if documentation is clearly part of the patient’s medical history; date of screening test must be documented regardless

Child and Adolescent Measures

  • Appropriate Testing for Pharyngitis (CWP)
    • Previously called Children with Pharyngitis
    • Expanded age range to 3 years and older
    • Medicare added
  • Childhood Immunization Status (CIS)
    • Added live attenuated influenza virus (LAIV) as compliant (intranasal flu vaccine)
  • Immunizations for Adolescents (IMA)
    • Documentation of immunizations under “meningococcal conjugate vaccine” or “meningococcal polysaccharide vaccine” meet criteria
  • Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC)
    • Referral to WIC will meet criteria for the Counseling for Nutrition CPT code

Diabetes – New CPT II Coding

  • Comprehensive Diabetes Care (CDC)
    • Effective 10/1/2019:
      • 2022F – Dilated Retinal Exam with evidence of retinopathy (Positive eye exam, 2019 only)
      • 2023F – Dilated Retinal Exam without evidence of retinopathy (Negative eye exam, 2018 or 2019) 
    • Effective 1/1/2020:
      • 3051F – Hemoglobin A1c ≥7.0% and <8.0%
      • 3052F – Hemoglobin ≥8.0% and ≤9.0%

New Measures for 2020

  • Follow-Up After High Intensity Care for Substance Use Disorder (FUI)
    • Number of patients 13 and older with substance use disorder (SUD) that received a follow-up after:
      • Acute inpatient hospitalization
      • Residential treatment
      • Detoxification visits or discharges
    • Must receive a follow-up within:
      • 7 days after the visit or discharge, and
      • 30 days after the visit or discharge
  • Pharmacotherapy for Opioid Use Disorder (POD)
    • Number of patients 16 and older with opioid use disorder (OUD) who receive 180 continuous days of OUD medication treatment

Coding to the highest specificity year-round will minimize medical record requests from us. If you have questions or you’d like coding guidance, please contact your BlueCross BlueShield account representative. Click on the link below to view the full list of HEDIS 2020 changes on our provider website incentives page.

Recent Articles

  • Individual Provider Recontracting Initiative
    We will be amending and restating our existing contracts. Starting next month, all directly contracted individual providers will be sent an updated contract. The New York State Department of Health (DOH) requires that each provider sign and return their amended/restated contract.
  • New Digital Provider and Facility Reference Manual
    We’ve upgraded our Provider and Facility Reference Manual, which is now available in digital format. The new manual offers a better, more interactive user experience. Here, we highlight some of the new features.
  • Updates to Screening for Hepatitis C Virus (HCV) in Adults
    Hepatitis C virus (HCV) is reportedly the most common blood infection in the country. The U.S. Preventive Services Task Force has updated the recommendation for HCV screening in March 2020 to now include all adults ages 18 to 79 without known liver disease, regardless of their risk for infection.
  • Update to Spine Preauthorization Process
    To help streamline the preauthorization process for spine procedures and injections, all these requests will be submitted directly to our Utilization Management Department beginning October 1, 2020. We will no longer require any requests to be submitted through Palladian Health.
  • Care at Home Expanded for Medicare Advantage Patients
    Beginning on July 7, more Medicare Advantage patients will be eligible to enroll in a new extension of the Care at Home program -- Care at Home℠ On Call -- which offers some urgent care in-home services. Care at Home On Call will be offered to newly enrolled Medicare Advantage members.

Working with Us

Additional Resources

We want to hear from you! Have a topic request for the next Blue Bulletin? Email us

Stay in Touch! Sign up to receive emails for provider news and information